MedPath

Pilot study of the digital health application Uroli based on the BfArM guideline The Fast Track Procedure for Digital Health Applications (DiGA) according to §139e SGB V.

Not Applicable
Conditions
N20
Calculus of kidney and ureter
Registration Number
DRKS00029633
Lead Sponsor
Medipee GmbH
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
50
Inclusion Criteria

Patients with renal/ureteral stone (ICD-10: N20) who require personalized stone metaphylaxis, regardless of stone type and regardless of initial occurrence or recurrence; individuals 18 years of age and older; regular use of a smartphone, including use of apps to ensure usability of the Uroli app; accessibility via e-mail

Exclusion Criteria

Patients with acute symptoms of urolithiasis; Patients who are medically judged to be limited in fluid intake due to other medical conditions or patients with markedly impaired renal function as defined by a serum creatinine level >2mg/dl; Individuals who have been determined by an investigator to be unable to participate in the study; Individuals under the age of 18; Not owning or regularly using their own smartphone; Not having their own email address; Individuals without consent to participate in the study.

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Study Objective:<br>To evaluate the effectiveness of the Uroli app in supporting metaphylaxis of adult patients with urolithiasis after acute treatment of a renal or ureteral stone compared to metaphylaxis without the Uroli app in terms of medical benefit and patient-relevant structural and procedural improvements.<br><br>The individual endpoints defined, including the measurement instruments used for this purpose, can be found in the attached study document ( Endpoints).<br><br>The measurement variables will be collected at T0 and after 3 months (T1).<br><br>Translated with www.DeepL.com/Translator (free version)
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath